Cresco Labs (CRLBF) Change in Working Capital (2023)

Cresco Labs (CRLBF) reported Change in Working Capital of $92000.0 for Q1 2023.

Cresco Labs (CRLBF) Change in Working Capital (2023) Analysis & Trends

Cresco Labs has reported Change in Working Capital for 1 years, with the latest figure at $92000.0 in Q1 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Working Cap. (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn -617.00 Mn
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn -
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn -
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn 215.05 Mn
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn -
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn -
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn -
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn -
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn -
10 Cresco Labs - - 75.45 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2023 92,000.00
Mar 31, 2023 92,000.00